Literature DB >> 25892232

Central role of ULK1 in type I interferon signaling.

Diana Saleiro1, Swarna Mehrotra1, Barbara Kroczynska1, Elspeth M Beauchamp2, Pawel Lisowski3, Beata Majchrzak-Kita4, Tushar D Bhagat5, Brady L Stein1, Brandon McMahon1, Jessica K Altman2, Ewa M Kosciuczuk1, Darren P Baker6, Chunfa Jie1, Nadereh Jafari1, Craig B Thompson7, Ross L Levine8, Eleanor N Fish4, Amit K Verma5, Leonidas C Platanias9.   

Abstract

We provide evidence that the Unc-51-like kinase 1 (ULK1) is activated during engagement of the type I interferon (IFN) receptor (IFNR). Our studies demonstrate that the function of ULK1 is required for gene transcription mediated via IFN-stimulated response elements (ISRE) and IFNγ activation site (GAS) elements and controls expression of key IFN-stimulated genes (ISGs). We identify ULK1 as an upstream regulator of p38α mitogen-activated protein kinase (MAPK) and establish that the regulatory effects of ULK1 on ISG expression are mediated possibly by engagement of the p38 MAPK pathway. Importantly, we demonstrate that ULK1 is essential for antiproliferative responses and type I IFN-induced antineoplastic effects against malignant erythroid precursors from patients with myeloproliferative neoplasms. Together, these data reveal a role for ULK1 as a key mediator of type I IFNR-generated signals that control gene transcription and induction of antineoplastic responses.
Copyright © 2015 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25892232      PMCID: PMC4477687          DOI: 10.1016/j.celrep.2015.03.056

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  65 in total

1.  Essential role for the Mnk pathway in the inhibitory effects of type I interferons on myeloproliferative neoplasm (MPN) precursors.

Authors:  Swarna Mehrotra; Bhumika Sharma; Sonali Joshi; Barbara Kroczynska; Beata Majchrzak; Brady L Stein; Brandon McMahon; Jessica K Altman; Jonathan D Licht; Darren P Baker; Elizabeth A Eklund; Amittha Wickrema; Amit Verma; Eleanor N Fish; Leonidas C Platanias
Journal:  J Biol Chem       Date:  2013-06-28       Impact factor: 5.157

2.  The serine/threonine kinase ULK1 is a target of multiple phosphorylation events.

Authors:  Markus Bach; Mark Larance; David E James; Georg Ramm
Journal:  Biochem J       Date:  2011-12-01       Impact factor: 3.857

3.  Critical roles for Rictor/Sin1 complexes in interferon-dependent gene transcription and generation of antiproliferative responses.

Authors:  Surinder Kaur; Barbara Kroczynska; Bhumika Sharma; Antonella Sassano; Ahmet Dirim Arslan; Beata Majchrzak-Kita; Brady L Stein; Brandon McMahon; Jessica K Altman; Bing Su; Raffaele A Calogero; Eleanor N Fish; Leonidas C Platanias
Journal:  J Biol Chem       Date:  2014-01-27       Impact factor: 5.157

Review 4.  The renaissance of interferon therapy for the treatment of myeloid malignancies.

Authors:  Jean-Jacques Kiladjian; Ruben A Mesa; Ronald Hoffman
Journal:  Blood       Date:  2011-03-09       Impact factor: 22.113

Review 5.  Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins.

Authors:  J E Darnell; I M Kerr; G R Stark
Journal:  Science       Date:  1994-06-03       Impact factor: 47.728

6.  Dual regulatory roles of phosphatidylinositol 3-kinase in IFN signaling.

Authors:  Surinder Kaur; Antonella Sassano; Ajith M Joseph; Beata Majchrzak-Kita; Elizabeth A Eklund; Amit Verma; Saskia M Brachmann; Eleanor N Fish; Leonidas C Platanias
Journal:  J Immunol       Date:  2008-11-15       Impact factor: 5.422

Review 7.  Regulation of type I interferon responses.

Authors:  Lionel B Ivashkiv; Laura T Donlin
Journal:  Nat Rev Immunol       Date:  2014-01       Impact factor: 53.106

8.  Type I interferon (IFN)-dependent activation of Mnk1 and its role in the generation of growth inhibitory responses.

Authors:  Sonali Joshi; Surinder Kaur; Amanda J Redig; Katy Goldsborough; Kevin David; Takeshi Ueda; Rie Watanabe-Fukunaga; Darren P Baker; Eleanor N Fish; Rikiro Fukunaga; Leonidas C Platanias
Journal:  Proc Natl Acad Sci U S A       Date:  2009-07-02       Impact factor: 11.205

Review 9.  New function of type I IFN: induction of autophagy.

Authors:  Hana Schmeisser; Joseph Bekisz; Kathryn C Zoon
Journal:  J Interferon Cytokine Res       Date:  2014-01-15       Impact factor: 2.607

10.  Ulk1 plays a critical role in the autophagic clearance of mitochondria and ribosomes during reticulocyte maturation.

Authors:  Mondira Kundu; Tullia Lindsten; Chia-Ying Yang; Junmin Wu; Fangping Zhao; Ji Zhang; Mary A Selak; Paul A Ney; Craig B Thompson
Journal:  Blood       Date:  2008-06-06       Impact factor: 22.113

View more
  35 in total

1.  Interferon γ (IFNγ) Signaling via Mechanistic Target of Rapamycin Complex 2 (mTORC2) and Regulatory Effects in the Generation of Type II Interferon Biological Responses.

Authors:  Barbara Kroczynska; Robert L Rafidi; Beata Majchrzak-Kita; Ewa M Kosciuczuk; Gavin T Blyth; Jacek Jemielity; Zofia Warminska; Diana Saleiro; Swarna Mehrotra; Ahmet Dirim Arslan; Eleanor N Fish; Leonidas C Platanias
Journal:  J Biol Chem       Date:  2015-12-08       Impact factor: 5.157

2.  The long noncoding RNA Morrbid regulates CD8 T cells in response to viral infection.

Authors:  Jonathan J Kotzin; Fany Iseka; Jasmine Wright; Megha G Basavappa; Megan L Clark; Mohammed-Alkhatim Ali; Mohamed S Abdel-Hakeem; Tanner F Robertson; Walter K Mowel; Leonel Joannas; Vanessa D Neal; Sean P Spencer; Camille M Syrett; Montserrat C Anguera; Adam Williams; E John Wherry; Jorge Henao-Mejia
Journal:  Proc Natl Acad Sci U S A       Date:  2019-05-28       Impact factor: 11.205

3.  Immune Escape via a Transient Gene Expression Program Enables Productive Replication of a Latent Pathogen.

Authors:  Jessica A Linderman; Mariko Kobayashi; Vinayak Rayannavar; John J Fak; Robert B Darnell; Moses V Chao; Angus C Wilson; Ian Mohr
Journal:  Cell Rep       Date:  2017-01-31       Impact factor: 9.423

4.  Reduction of infection by inhibiting mTOR pathway is associated with reversed repression of type I interferon by porcine reproductive and respiratory syndrome virus.

Authors:  Qinfang Liu; Laura C Miller; Frank Blecha; Yongming Sang
Journal:  J Gen Virol       Date:  2017-06-14       Impact factor: 3.891

Review 5.  The molecular basis for differential type I interferon signaling.

Authors:  Gideon Schreiber
Journal:  J Biol Chem       Date:  2017-03-13       Impact factor: 5.157

Review 6.  Interferon signaling in cancer. Non-canonical pathways and control of intracellular immune checkpoints.

Authors:  Diana Saleiro; Leonidas C Platanias
Journal:  Semin Immunol       Date:  2019-06       Impact factor: 11.130

7.  Regulation of ULK1 Expression and Autophagy by STAT1.

Authors:  Alexander A Goldberg; Bernard Nkengfac; Anthony M J Sanchez; Nikolay Moroz; Salman T Qureshi; Antonis E Koromilas; Shuo Wang; Yan Burelle; Sabah N Hussain; Arnold S Kristof
Journal:  J Biol Chem       Date:  2016-12-23       Impact factor: 5.157

8.  Sirtuin 2-mediated deacetylation of cyclin-dependent kinase 9 promotes STAT1 signaling in type I interferon responses.

Authors:  Ewa M Kosciuczuk; Swarna Mehrotra; Diana Saleiro; Barbara Kroczynska; Beata Majchrzak-Kita; Pawel Lisowski; Caroline Driehaus; Anna Rogalska; Acara Turner; Thomas Lienhoop; David Gius; Eleanor N Fish; Athanassios Vassilopoulos; Leonidas C Platanias
Journal:  J Biol Chem       Date:  2018-11-28       Impact factor: 5.157

9.  Type I Interferons Act Directly on Nociceptors to Produce Pain Sensitization: Implications for Viral Infection-Induced Pain.

Authors:  Paulino Barragán-Iglesias; Úrzula Franco-Enzástiga; Vivekanand Jeevakumar; Stephanie Shiers; Andi Wangzhou; Vinicio Granados-Soto; Zachary T Campbell; Gregory Dussor; Theodore J Price
Journal:  J Neurosci       Date:  2020-04-03       Impact factor: 6.167

Review 10.  Beyond autophagy: New roles for ULK1 in immune signaling and interferon responses.

Authors:  Diana Saleiro; Ewa M Kosciuczuk; Leonidas C Platanias
Journal:  Cytokine Growth Factor Rev       Date:  2016-04-01       Impact factor: 7.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.